IRTC IRhythm Technologies Inc.

iRhythm Technologies to Participate in Two Investor Conferences in September

iRhythm Technologies to Participate in Two Investor Conferences in September

SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE) --  (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the Company will be participating in the upcoming Baird 2023 Global Healthcare Conference and the Morgan Stanley 21st Annual Global Healthcare Conference.

iRhythm’s management is scheduled to present at Baird’s 2023 Global Healthcare Conference on Tuesday, September 12, at 9:05 am Eastern Time and at the Morgan Stanley Global Healthcare Conference on Wednesday, September 13, at 1:35 pm Eastern Time. Those interested in listening to the presentation may do so by accessing the live and archived webcast of the events, which will be available on the investors section of the Company’s website at .

About iRhythm Technologies, Inc.

iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Relations Contact

Stephanie Zhadkevich

(919) 452-5430

iRhythm Media Contact:

Saige Smith

(262) 289-7065



EN
29/08/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IRhythm Technologies Inc.

 PRESS RELEASE

iRhythm Technologies Announces First Quarter 2024 Financial Results

iRhythm Technologies Announces First Quarter 2024 Financial Results SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2024. First Quarter 2024 Financial Highlights Revenue of $131.9 million, a 18.4% increase compared to first quarter 2023Gross margin of 66.3%, a 160-basis point decline compared to first quarter 2023Unrestricted cash, cash equivalents and marketable securitie...

 PRESS RELEASE

iRhythm Technologies to Report First Quarter 2024 Financial Results on...

iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024 SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on Thursday, May 2, 2024. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the presentation...

 PRESS RELEASE

iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Seni...

iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced today the closing of its offering of 1.50% Convertible Senior Notes due 2029 (the “notes”) for gross proceeds of $661.25 million in a private placement to persons reasona...

 PRESS RELEASE

iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible...

iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029 SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced today the pricing of its offering of $575.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Secu...

 PRESS RELEASE

iRhythm Announces Proposed Offering of $450.0 Million of Convertible S...

iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and help prevent disease, announced today that it intends to offer, subject to market conditions and other factors, $450.0 million aggregate principal amount of Convertible Senior Notes due 2029 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch